BlackRock
FURX

BlackRock’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-176
Closed -$19K – 3229
2014
Q2 		$19K Sell
176
-347
-66% -$34K ﹤0.01% 2425
2014
Q1 		$46K Buy
523
+344
+192% +$26.6K ﹤0.01% 1956
2013
Q4 		$8K Hold
179
– – ﹤0.01% 2895
2013
Q3 		$8K Hold
179
– – ﹤0.01% 2831
2013
Q2 		$6K Buy
+179
New +$6.28K ﹤0.01% 3011

BlackRock's FURX Position: Q3 2014 in Review

BlackRock sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 176 shares — an estimated $19K sold.

BlackRock first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $46K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock sold 176 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $19K.
  • BlackRock first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • BlackRock's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $46K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock's 13F filing for Q3 2014, filed 29 Oct 2014.